Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?
- 15 March 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (11) , 1318-1328
- https://doi.org/10.1038/sj.onc.1204253
Abstract
Since autocrine regulation of HGF-Met is implicated in many forms of human cancer, we investigated whether the predisposition to develop ovarian cancer in women with hereditary ovarian cancer syndromes involves changes in the expression of HGF-Met by the tissue of origin of epithelial ovarian cancers, the ovarian surface epithelium (OSE). We compared cultures of normal OSE from women with (FH-OSE) (n = 20) and with no (NFH-OSE) (n=48) family histories of ovarian cancer, SV40 Tag immortalized OSE lines (IOSE, n=5) and ovarian cancer cell lines (n=3). Cultures derived from 21/22 women with NFH-OSE and 13/13 women with FH-OSE expressed Met mRNA initially. After two to three passages, Met was downregulated in 37% of NFH-OSE cultures but persisted in 100% of FH-OSE cultures and ovarian cancer lines, like other epithelial differentiation markers that are stabilized in FH-OSE and neoplasia. HGF and Met mRNA were concomitantly expressed by NFH-OSE from only three of 32 women but in FH-OSE from eight of 13 women, and also in five of five IOSE and two of three ovarian cancer lines. Conditioned media from FH-OSE, but not NFH-OSE, contained immunoreactive HGF and induced cohort migration which was inhibited by neutralizing HGF antibody. Several signaling molecules of the PI3K pathway, including Akt2 and p70 S6K, were constitutively activated in FH-OSE from six of six women but in NFH-OSE from only four of eight women. Exogenous HGF was mitogenic in OSE, and that effect was regulated through the MAP kinase (ERK1/ERK2) and FRAP/p70 S6K pathways. The proliferative response to HGF was greater in NFH-OSE than in FH-OSE cultures. The results show that FH-OSE cultures differ from NFH-OSE by increased stability of Met expression and by HGF secretion. Constitutive phosphorylation of kinases and a diminished growth response to HGF suggest the presence of autocrine regulation in FH-OSE. In analogy with other cell types where an autocrine HGF-Met loop has been implicated in tumorigenic transformation, this change in FH-OSE may play a role in the enhanced susceptibility to ovarian carcinogenesis in women with hereditary ovarian cancer syndromes.link_to_subscribed_fulltexKeywords
This publication has 36 references indexed in Scilit:
- Hepatocyte Growth Factor Induces Rat Ovarian Surface Epithelial Cell Mitosis or Apoptosis Depending on the Presence or Absence of an Extracellular Matrix*Endocrinology, 1999
- Evidence that hepatocyte growth factor abrogates contact inhibition of mitosis in Madin-Darby canine kidney cell monolayersLife Sciences, 1999
- Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-METInternational Journal of Cancer, 1997
- Opposing Actions of Hepatocyte Growth Factor and Basic Fibroblast Growth Factor on Cell Contact, Intracellular Free Calcium Levels, and Rat Ovarian Surface Epithelial Cell ViabilityEndocrinology, 1997
- Autonomy of the epithelial phenotype in human ovarian surface epithelium: Changes with neoplastic progression and with a family history of ovarian cancerInternational Journal of Cancer, 1996
- Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells.The Journal of cell biology, 1995
- Expression of two mucin antigens in cultured human ovarian surface epithelium: Influence of a family hostory of ovarian cancerPublished by Elsevier ,1995
- Overexpression of theMET/HGF receptor in ovarian cancerInternational Journal of Cancer, 1994
- Comparison of the Neutral Red and Methylene Blue Assays to Study Cell Growth in CultureBiotechnic & Histochemistry, 1993
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991